Physician profile
Jin Zhou
NPI 1437593118
$2,250.71
in general payments reported to CMS, 2019-2025
12 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $82.96 · 2023: $345 · 2024: $547 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,979 · Education: $14.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,978.83 |
| Education | $14.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,181.49 | 2021-2025 | Ubrelvy, Qulipta |
| Pfizer INC. | $300.44 | 2023-2025 | |
| Axsome Therapeutics, INC. | $167.53 | 2025 | Symbravo |
| Alexion Pharmaceuticals, INC. | $128.63 | 2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $106.63 | 2025 | |
| Eisai INC. | $97.49 | 2025 | |
| Ucb, INC. | $90.17 | 2025 | Rystiggo, Zilbrysq |
| Biohaven Pharmaceutical Holding Company LTD. | $69.51 | 2022 | |
| Lilly USA, LLC | $52.80 | 2025 | Kisunla |
| Abbott Laboratories | $24.00 | 2024 | Infinity |
| Scilex Pharmaceuticals INC. | $17.39 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $14.63 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.